Document is current

Article History

Received: 30 May 2024

Accepted: 21 October 2024

First Online: 11 December 2024

Compliance with ethical standards

:

: The scientific guarantor of this publication is Michael Schwarz.

: The authors of this manuscript declare relationships with the following companies: M.S. received travel support from MSD, Sandoz, BMS, AbbVie and Gilead; and speaking honoraria from BMS and Gilead. C.S. received travel support from Gilead, Abbvie, and Gebro; speaking honoraria from Abbvie and Gilead; and payments for consulting from Gilead. J.B. received speaking honoraria from Roche Diagnostics and honoraria from Biomarin (advisory board for Achondroplasia). T.R. received grant support from Abbvie, Boehringer Ingelheim, Gilead, Intercept/Advanz Pharma, MSD, Myr Pharmaceuticals, Philips Healthcare, Pliant, Siemens and W. L. Gore & Associates; speaking honoraria from Abbvie, Gilead, Intercept/Advanz Pharma, Roche, MSD, W. L. Gore & Associates; consulting/advisory board fee from Abbvie, Astra Zeneca, Bayer, Boehringer Ingelheim, Gilead, Intercept/Advanz Pharma, MSD, Resolution Therapeutics, Siemens; and travel support from Abbvie, Boehringer Ingelheim, Dr. Falk Pharma, Gilead and Roche. M.W. is a member of the Scientific Editorial Board of European Radiology (section: Chest). They did not participate in the selection or review processes for this article. The remaining authors declare no potential conflicts of interest.

: No complex statistical methods were necessary for this paper.

: Written informed consent was obtained from all subjects (patients) in this study.

: Institutional Review Board approval was obtained.

: No overlap.

: